title: Testosterone replacement therapy faces FDA scrutiny.
authors.affiliation: Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusetts.
authors.forename: Marc B
authors.initials: MB
authors.lastname: Garnick
mesh_terms: D000328:Adult; D026683:Advisory Committees; D000368:Aged; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D017277:Drug Approval; D004348:Drug Labeling; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D007006:Hypogonadism / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013739:Testosterone / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D013739:Testosterone